Gliomas in adults: Guidance on investigations, diagnosis, treatment and surveillance

被引:1
作者
Lerner, Anna [1 ]
Palmer, Kieran [1 ]
Campion, Tom [2 ]
Millner, Thomas [3 ,4 ]
Scott, Emily [1 ]
Lorimer, Cressida [5 ]
Paraskevopoulos, Dimitrios [1 ]
Mckenna, Grainne [1 ]
Marino, Silvia [3 ,4 ]
Lewis, Rachel [1 ]
Plowman, Nick [1 ]
机构
[1] Barts Hlth NHS Trust, London, England
[2] Barts Hlth NHS Trust, Imaging Dept, London, England
[3] Queen Mary Univ London, Blizard Inst, London, England
[4] Barts Hlth NHS Trust, London, England
[5] Univ Hosp Sussex NHS Fdn Trust, Worthing, England
关键词
Glioma; Presentation; Diagnosis; Management; Complications; PHASE-III TRIAL; VINCRISTINE CHEMOTHERAPY; RESPONSE ASSESSMENT; PLUS PROCARBAZINE; BRAIN-TUMORS; GLIOBLASTOMA; TEMOZOLOMIDE; RESECTION; OLIGODENDROGLIOMA; RADIOTHERAPY;
D O I
10.1016/j.clinme.2024.100240
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary brain tumours are rare but carry a significant morbidity and mortality burden. Malignant gliomas are the most common subtype and their incidence is increasing within our ageing population. The diagnosis and treatment of gliomas involves substantial interplay between multiple specialties, including general medical physicians, radiologists, pathologists, surgeons, oncologists and allied health professionals. At any point along this pathway, patients can present to acute medicine with complications of their cancer or anti-cancer therapy. Increasing the awareness of malignant gliomas among general physicians is paramount to delivering prompt radiological and histopathological diagnoses, facilitating access to earlier and individualised treatment options and allows for effective recognition and management of anticipated complications. This article discusses evidence-based real-world practice for malignant gliomas, encompassing patient presentation, diagnostic pathways, treatments and their complications, and prognosis to guide management outside of specialist centres.
引用
收藏
页数:9
相关论文
共 51 条
  • [1] Alentorn Agusti, 2016, Handb Clin Neurol, V134, P19, DOI 10.1016/B978-0-12-802997-8.00002-5
  • [2] [Anonymous], 2023, NCCN Clinical Practice Guidelines in Oncology
  • [3] [Anonymous], 2023, Implementing Frailty Assessment and Management in Oncology Services
  • [4] [Anonymous], Overview: Brain tumours (primary) and brain metastases in over 16s Overview | Brain tumours (primary) and brain metastases in over 16s | Guidance
  • [5] Oncolytic immunovirotherapy for high-grade gliomas: A novel and an evolving therapeutic option
    Asija, Sweety
    Chatterjee, Abhishek
    Goda, Jayant S. S.
    Yadav, Sandhya
    Chekuri, Godhanjali
    Purwar, Rahul
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [6] Primary brain tumours in adults
    Behin, A
    Hoang-Xuan, K
    Carpentier, AF
    Delattre, JY
    [J]. LANCET, 2003, 361 (9354) : 323 - 331
  • [7] Risk factors and prognostic implications of surgery-related strokes following resection of high-grade glioma
    Berger, Assaf
    Tzarfati, Garry Gali
    Serafimova, Marga
    Valdes, Pablo
    Meller, Aaron
    Korn, Akiva
    Levy, Naomi Kahana
    Aviram, Daniel
    Ram, Zvi
    Grossman, Rachel
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [8] Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
    Buckner, Jan C.
    Shaw, Edward G.
    Pugh, Stephanie L.
    Chakravarti, Arnab
    Gilbert, Mark R.
    Barger, Geoffrey R.
    Coons, Stephen
    Ricci, Peter
    Bullard, Dennis
    Brown, Paul D.
    Stelzer, Keith
    Brachman, David
    Suh, John H.
    Schultz, Christopher J.
    Bahary, Jean-Paul
    Fisher, Barbara J.
    Kim, Harold
    Murtha, Albert D.
    Bell, Erica H.
    Won, Minhee
    Mehta, Minesh P.
    Curran, Walter J., Jr.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (14) : 1344 - 1355
  • [9] Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
    Cairncross, Gregory
    Wang, Meihua
    Shaw, Edward
    Jenkins, Robert
    Brachman, David
    Buckner, Jan
    Fink, Karen
    Souhami, Luis
    Laperriere, Normand
    Curran, Walter
    Mehta, Minesh
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (03) : 337 - 343
  • [10] Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
    Cloughesy, Timothy F.
    Mochizuki, Aaron Y.
    Orpilla, Joey R.
    Hugo, Willy
    Lee, Alexander H.
    Davidson, Tom B.
    Wang, Anthony C.
    Ellingson, Benjamin M.
    Rytlewski, Julie A.
    Sanders, Catherine M.
    Kawaguchi, Eric S.
    Du, Lin
    Li, Gang
    Yong, William H.
    Gaffey, Sarah C.
    Cohen, Adam L.
    Mellinghoff, Ingo K.
    Lee, Eudocia Q.
    Reardon, David A.
    O'Brien, Barbara J.
    Butowski, Nicholas A.
    Nghiemphu, Phioanh L.
    Clarke, Jennifer L.
    Arrillaga-Romany, Isabel C.
    Colman, Howard
    Kaley, Thomas J.
    De Groot, John F.
    Liau, Linda M.
    Wen, Patrick Y.
    Prins, Robert M.
    [J]. NATURE MEDICINE, 2019, 25 (03) : 477 - +